Skip to main content
Premium Trial:

Request an Annual Quote

Structural Genomix Appoints Prospect Genomics Founder, Exelixis Founder to Board

NEW YORK, July 19 - Structural Genomix has appointed Bill Rutter and Stelios Papadopoulos to the company's board of directors, the company said Thursday.

Rutter is a co-founder of Prospect Genomics, a San Francisco-based developer of protein structure prediction software  that was acquired in April by Structural Genomix. In addition, Rutter is a founder and chairman emeritus of Chiron, and has served as chairman of the biochemistry and biophysics department at the University of California, San Francisco.

Papadopoulos currently serves as a managing director in investment banking at SG Cowen, specializing in the biotechnology and pharmaceutical sectors. He is a founder and chairman of the board of Exelixis, and a founder and director of Anadys Pharmaceuticals, CellZome, and CellFate.

The addition of Papadopoulos and Rutter brings the number of company directors to eight.

"With their collective knowledge and experience in drug discovery, investment banking, and management, Stelios and Bill bring tremendous value to our board," George Poste, chairman of Structural Genomix, said in a statement. "Stelios' commitment to strategic business development will facilitate SGX's success, while Bill's background in both academia and commercial life sciences will ensure SGX's dedication to both innovation and sound operations."  
The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.